INO vs BIIB: Which Stock is Better?
Side-by-side comparison of Inovio Pharmaceuticals Inc and Biogen Inc in 2026
INO
Inovio Pharmaceuticals Inc
$1.19
BIIB
Biogen Inc
$180.54
Key Metrics Comparison
| Metric | INO | BIIB | Winner |
|---|---|---|---|
| Market Cap | $90.57M | $26.50B | BIIB |
| P/E Ratio | N/A | 20.54 | BIIB |
| EPS (TTM) | $N/A | $8.79 | BIIB |
| Revenue Growth | -1.0% | -0.1% | BIIB |
| Gross Margin | -82857.4% | 78.9% | BIIB |
Analyze INO
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is INO or BIIB a better investment?
Comparing INO and BIIB: Inovio Pharmaceuticals Inc has a market cap of $90.57M while Biogen Inc has $26.50B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between INO and BIIB?
INO (Inovio Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: INO or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: INO or BIIB?
BIIB has higher revenue growth at -0.1% vs -1.0% for INO.
Which company is more profitable: INO or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -82857.4% for INO.
Which is the larger company: INO or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $26.50B compared to $90.57M for INO.
Should I buy INO or BIIB in 2026?
Both INO and BIIB have investment merit. INO trades at $1.19 while BIIB trades at $180.54. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between INO and BIIB stock?
Key differences: Market Cap ($90.57M vs $26.50B), P/E Ratio (N/A vs 20.5x), Revenue Growth (-1.0% vs -0.1%), Gross Margin (-82857.4% vs 78.9%).